Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. (Q50966333)
Jump to navigation
Jump to search
scientific article published on 10 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. |
scientific article published on 10 February 2012 |
Statements
1 reference
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. (English)
1 reference
Tanja D de Gruijl
1 reference
Alfons J M van den Eertwegh
1 reference
Jurjen Versluis
1 reference
H Pieter van den Berg
1 reference
Saskia J A M Santegoets
1 reference
R Jeroen A van Moorselaar
1 reference
Tim M van der Sluis
1 reference
Helen E Gall
1 reference
Thomas C Harding
1 reference
Karin Jooss
1 reference
Israel Lowy
1 reference
Herbert M Pinedo
1 reference
Rik J Scheper
1 reference
Anita G M Stam
1 reference
B Mary E von Blomberg
1 reference
Kristen Hege
1 reference
Natalie Sacks
1 reference
Winald R Gerritsen
1 reference
10 February 2012
1 reference
13
1 reference
5
1 reference
509-517
1 reference
Identifiers
1 reference